Pfizer Inc. et al v. Ajanta Pharma Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 18, 2018 | 6 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Order of Dismissal, by Pfizer Inc., Pfizer Limited. (Noreika, Maryellen) Modified on 4/18/2018 (nms). |
| Apr 18, 2018 | 7 | Order (2) Docket Text: SO ORDERED Granting [6] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 4/18/2018. (nms) |
| Apr 18, 2018 | 8 | Patent/Trademark Report to Commissioner (1) |
| Apr 18, 2018 | 8 | Order (2) |
| Apr 18, 2018 | 8 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,469,012 B1. (Attachments: # (1) Order)(nms) |
| Feb 7, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) |
| Feb 1, 2018 | 1 | Complaint (7) |
| Feb 1, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Ajanta Pharma Ltd. on 2/1/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Feb 1, 2018 | 1 | Exhibit A (48) |
| Feb 1, 2018 | 1 | Civil Cover Sheet (1) |
| Feb 1, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Feb 1, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/26/2017. Date of Expiration of Patent: 4/22/2020.Thirty Month Stay Deadline: 6/26/2020. (ceg) |
| Feb 1, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,469,012 B1. (ceg) |
| Feb 1, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for Pfizer Limited filed by Pfizer Inc., Pfizer Limited. (ceg) |
| Feb 1, 2018 | 1 | Main Document (7) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Ajanta Pharma Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2313469.) - filed by Pfizer Limited, Pfizer Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(ceg) |
| Feb 1, 2018 | 1 | Complaint* (1) |
